Introduction
Historically, electrophysiological activity has been recorded with amplifiers using cutaneous or implanted electrodes to pick up the biological signal and dates back to the work of Einthoven in 1901. The displacement of ionic charge inside biological tissues during heart or neuronal activity builds up a voltage which can be read with low impedance electrodes. However, on the way to the amplifier, this biological information is disturbed by ambient noise such as the characteristic AC signal from the building's power supply. This can become particularly challenging in environments such as an operating theater in a hospital where strong lights, space limitations, and sophisticated medical tools provide high electrical noise. This is compounded by the fact that the amplitude of electrophysiological signals is typically very low. One way to bypass such problems is to use active transducing amplifiers that are in direct contact with the biological medium. This provides a first stage amplification at the recording site, making the signal less sensitive to further noise pickup.
A promising candidate for such a transducing amplifier is the electrolyte gated organic electrochemical transistor (OECT), a three terminal device with key properties such as low operation voltage, high transconductance, and biocompatibility. The use of the conducting polymer poly(3,4‐ethylenedioxythiophene) doped with poly(styrene sulfonate) (PEDOT:PSS) as active material leads to an improved bioelectronic interface and recent studies have attributed this fact to the mixed ionic and electronic conduction where ions are able to penetrate into the bulk of the material. Easy fabrication with low temperature processing techniques, such as photolithography, screen printing, or inkjet printing, provide a future perspective for large scale manufacturing of flexible, disposable, and reasonably priced sensor devices on a broad range of substrates. As such, the OECT has proven worthy in various biosensing scenarios, e.g., in vitro detection of ions, specific metabolites and nucleotides, real‐time monitoring of barrier tissue integrity, and in vivo recordings of electrophysiological activity.
The OECT in its regular configuration, i.e., a constant source–drain bias and a gate that is connected to the source and immersed in an electrolyte covering the active material, provides a drain current ID that is modulated by the gate voltage VGS. Cations injected in the active material upon applying a positive gate voltage compensate sulfonate anions on the PSS chain, thus reducing the number of holes in the film by electrochemically dedoping the conducting polymer. Campana et al. demonstrated a direct cutaneous implementation of an OECT on a resorbable bioscaffold for transient applications in electrocardiographic (ECG) recordings. This way, the amplifying transducer is brought directly to the site of interest, reducing the power‐line interference and allowing for an increased signal‐to‐noise ratio comparable to regular electrode measurements. In order to maintain high quality recordings for long‐term measurements, as needed for example in sports applications or telemedicine situations, hydrogels or ionic liquids gels are used to establish a better contact of electrophysiology devices with the skin. This reduces motion artifacts and maintains or lowers the impedance.
To make the OECT compatible with existing voltage recording equipment for electrophysiological measurements, we need to convert the current output into a voltage signal. In this article, we focus on the integration of the OECT into a simple voltage amplifier circuit to provide a voltage‐to‐voltage transduction, as first introduced by Rivnay et al. A detailed investigation of this system allows us to optimize the amplification parameters of the device. We find an increased performance when biasing the OECT in the saturation regime with a linear amplification of up to 30 V/V. To validate our system, we demonstrate recordings of electrocardiographic signals with a regular medical recording system. This work leads to a better understanding of OECT‐based circuits and paves the way for their use as active organic electrodes with traditional electrophysiology instrumentation.
Results and Discussion
To convert the current provided by the OECT into a readable voltage signal Vout we use a load resistor Rload on the drain side of the OECT (see Figure 1a). This acts as a voltage divider for the supply voltage Vsupply and lets the drain voltage Vout of the OECT float, i.e., there is no fixed source–drain bias anymore. Instead, the bias depends on the drain current
a) Schematic circuit layout of the voltage amplifier system with embedded OECT. b) Load line diagram of an OECT with aspect ratio of W/L = 2 and thickness of d = 70 nm using a drain load resistor of Rload = 500 Ω for saturation regime (blue) and linear regime (red). A 100 mm solution of sodium chloride is used as electrolyte. The gate voltage is varied from VGS = +0.4 V (light green) to −0.4 V (dark green) in steps of ∆VGS = 0.1 V. The black line indicates the output at VGS = 0 V and the open circles denote the corresponding operation point. The dashed lines are a guide to the eye and extend the saturation regime to the inaccessible data points assuming that the drain currents fully saturates. c–d) Transfer curve (dashed line) and transconductance (solid line) of the unloaded (black) versus the loaded OECT (colored) for linear regime c) and saturation regime d). The values of the drain current are extracted graphically via the intersection of the load line with the output curve at each value of VGS.
In analogy to the findings of Chou et al., we can derive a relationship between the transconductance of the loaded and the unloaded device, using the differential form of the drain current
From this relation, it becomes clear that in the saturation regime, where the drain current is independent of the source–drain bias (i.e., gid = 0), the voltage gain is directly proportional to the transconductance times the drain load resistor, whereas in the linear regime the voltage gain saturates for higher drain load as 1/Rload goes to zero (see Figure 2a). We compare this model to experimental data that have been retrieved by generating a sinusoidal signal with an amplitude ∆VGS = 1 mV and a frequency f = 2 Hz at the gate and recording the output voltage over a few cycles. We again distinguish between the linear and the saturation regime, meaning that we adjust Vout to obtain the given operation points (−0.2 V and −0.8 V) at VGS = 0 V for each value of the drain load resistor. The model shows remarkable agreement with the experimental data. Only at high drain load the voltage gain is overestimated in the saturation regime. This can be explained with the fact that at such a high voltage gain (> 20 V/V), a small inevitable drift in the drain current that derives for example from evaporation of the electrolyte also gets amplified by the same amount and consequently the operation point at zero gate bias is shifted toward higher source–drain bias.
a) Voltage gain ∆Vout/∆VGS for different drain load resistors for an input signal of ∆VGS = 1 mV in both the linear regime (red, OPlin = −0.2 V) and the saturation regime (blue, OPsat = −0.8 V). The channel resistance is Rload = 213 Ω and R0 = 513 Ω for the linear regime and saturation regime, respectively. The solid line shows an analytical model according to Equation . The same device is used as in Figure . b) Voltage gain ∆Vout/∆VGS for different aspect ratios for a drain load resistor of Rload = 500 Ω in the linear regime (red) and the saturation regime (blue). The points are calculated according to Equation using experimentally derived IV curves for each geometry. The thickness of the devices is d = 70 nm. The solid lines are a guide to the eye. c) Output voltage versus gate voltage for different drain load resistors for the same device as in Figure . The operation point at VGS = 0 V is set to −0.6 V. The values are extracted graphically via the intersection of the load line with the output curve at each value of VGS. Open symbols denote data outside the experimental limitation of |VGS – Vout| < 1 V, indicated by the dashed blue line, that allows for stable operation of the device.
Using Equation , we can also check the effect of device geometry for a given operation point and drain load resistor by using the intrinsic transconductance and drain conductance extracted from an IV curve of the plain OECT (see Figure b). It can be seen that again an overall higher gain can be achieved in the saturation regime. In the linear regime, the maximum gain can be obtained for aspect ratios of about W/L = 5 and in the saturation regime it seems to be at around W/L = 15. Rivnay et al. showed that the transconductance at VGS = 0 V increases for increasing aspect ratio until a certain point (for a channel thickness of d = 140 nm this is up to W/L ≈ 10, for d = 25 nm it is W/L > 10). This explains the findings in Figure b for the saturation regime as in this case the gain is directly proportional to the transconductance and the drain conductance can be neglected. In the linear regime, where the drain conductance is linear in W/L, the peak gain is shifted to lower aspect ratios as the drain conductance dominates in the denominator.
We emphasize the fact that this analytical derivation does not rely on any model for the OECT as it needs only the electrical characteristics (i.e., transconductance and drain conductance) of the plain transistor without any drain load. It is possible to arrive at an analytical expression and obtain similar findings using the Bernards model of the OECT. However, the agreement with the experimental data is not as good (see the Supporting Information) which can be mainly attributed to the fact that the Bernards model considers a constant mobility not describing the real physics of the device. For more complex models, such as the one recently published by Friedlein et al., this system becomes impossible to solve analytically due to the power dependence of the source–drain bias in the model.
One aspect that we neglected so far is the requirement of a high supply voltage at higher drain load to keep the same operation point at zero gate bias (see Equation ). As the PEDOT:PSS‐based OECT is a normally ON device and is shut down upon applying a positive gate voltage, the drain current is modulated from Imax to zero. In the same manner, the effective source–drain bias on the OECT, i.e., Vout, will vary from the set operation point up to Vsupply. This may lead to the unfortunate situation where the applied bias gets bigger than the electrochemical potential for water hydrolysis, inevitably destroying the device. In Figure c, the source–drain bias is plotted against the gate voltage for different drain load resistors. The steeper this curve is, the better the amplification. But the device gets out of the stable operation window |Vout − VGS| < 1 V at far lower gate voltage. In order to avoid any instability issues it is best to limit the input signal to low amplitudes or use a negative polarity for the gate signal, bearing in mind that this way the OECT is pushed back into the linear regime upon gating.
However, as we are interested in recording biological signals such as electrocardiograms (ECG) or electroencephalograms (EEG), and the amplitude of those signals is generally in the order of a few hundreds of microvolt, we can safely assume that at VGS = 0 V we stay within the stable operation window of the OECT. As a proof of concept, we use the OECT‐based voltage amplifier system for measuring heart activity. For this, we place two medical electrodes below the clavicle on the left and the right side of the chest and connect them to the source and the gate of the OECT (see Figure 3a). This way, the OECT is operated at VGS = (0 V + ECG) and the heart activity is doping or dedoping the channel. The medical electrodes provide a good contact with the skin and allow for an effective gating. We note that in this configuration, the OECT is not in contact with the skin, thus acting solely as an external preamplifier. Using this kind of configuration, we are able to control the value of the drain load resistor, which would not be possible in an all integrated solution. Due to the inherent voltage conversion at the drain load resistor, we can directly connect the output signal to a regular acquisition system for electrophysiology. For comparison, we record the heart activity with the OECT operated in linear and saturation regime. Upon varying the drain load resistor, we can modify the amplification of the signal (see Figure b). It can be seen that operating the OECT in the linear regime does not give any substantial amplification of the input signal. At best there is a one to one transduction for high drain load. As already stated in Figure a, the amplification saturates for values of Rload > 5 * Rchan. Nonetheless, a clear ECG signal can be seen with all relevant features of the PQRST complex (characteristic waves of the signal linked with propagation of muscle activity in the heart) for practically every value of the drain load resistor. The same holds when operating the device in the saturation regime with the difference being a much higher amplitude of the output signal and an amplification of as much as Gainsat = 30 V/V for the highest recorded drain load resistor Rload = 10 * Rchan. We note that the signal‐to‐noise ratio does not seem to change for the different recordings (see the Supporting Information) which can be mainly attributed to the fact that the experiment has been conducted in a low‐noise environment, inside a Faraday cage room.
a) Schematic of the experimental setup for ECG recordings. The output voltage Vout can be directly picked up by a regular voltage recording system. The medical electrodes (blue) are placed below the clavicle to the left and to the right of the heart. The system is driven by a battery. b) ECG recordings for different drain load in both linear and saturation regime. Each curve has been recorded consecutively with the same device. The channel dimensions of the OECT are W/L = 2 and d = 70 nm. The amplitude of the input signal recorded from the same electrodes was of the order of ∆VECG ≈ 300 μV. The recordings have been taken in a low noise environment.
Conclusion
We have successfully demonstrated the working principle of a voltage amplifier circuit based on a microfabricated organic electrochemical transistor with high transconductance using a simple resistor in series. This creates a floating voltage point that linearly depends on the drain current and can be used to transduce signals picked up by the OECT. As a proof of concept, we use the OECT‐based voltage amplifier externally in combination with medical electrodes. Characterization measurements show that a much better performance can be achieved upon driving the transistor in the saturation regime. In this case, the drain current is independent of the source–drain bias of the OECT and thus the output voltage depends directly on the input voltage at the gate of the OECT. We were able to record electrocardiographic signals by using a voltage recording system utilized for standard tests in a hospital. To our knowledge, this is the first time voltage‐to‐voltage amplifying transduction of electrophysiological activity has been demonstrated with an OECT, rendering this device directly useful in a clinical setup. Future work is ongoing to implement a gel electrolyte allowing for long‐term measurements directly on the skin to provide an active organic device that can be compared to regular electrodes.
Experimental Section
Device Fabrication: The devices were fabricated according to the parylene lift‐off method reported previously. Standard microscope glass slides were cleaned via sonication in an acetone and isopropyl alcohol solution and dried with nitrogen. Connection pads and interconnects were deposited through a lift‐off process using photolithographic patterning of positive photoresist (S1813) with a SUSS MJB4 broad band UV light mask aligner and MF‐26A developer. A subsequent metal deposition via evaporation of chromium (10 nm) and of gold (120 nm) and metal lift‐off using acetone defines the gold lines. A first layer of parylene C (2 μm), deposited via a SCS Labcoater 2 together with a small amount of 3‐(trimethoxysilyl)propyl methacrylate (A‐174 Silane) to enhance adhesion, acts as an insulator to prevent disturbing capacitive effects at the metal liquid interface. Subsequently, an antiadhesive layer was spin coated using a dilution of industrial cleaner (2%, Micro‐90) and a second parylene C sacrificial layer (2 μm) is deposited. To define the contact pads and the channel of the OECT, a second photolithographic patterning step using a thick positive photoresist (5 μm, AZ9260) and AZ developer is used to protect the parylene C layers from a subsequent plasma reactive ion etching step via an Oxford 80 Plasmalab plus (400 W, O2 = 50 sccm, CHF3 = 5 sccm, 8 min), at the point where no PEDOT:PSS is supposed to stay. The PEDOT:PSS solution was prepared mixing an aqueous dispersion (19 mL, Clevios PH‐1000 from Heraeus Holding GmbH) with ethylene glycol (1 mL) and dodecyl benzene sulfonic acid (50 μL), to improve conductivity and enhance film formation and sonicating for 40 min, then adding (3‐glycidyloxypropyl) trimethoxysilane (1 wt%), to prevent delamination of the film and sonicating for another 5 min. This dispersion was spincoated for a target thickness of about 90 nm (3000 rpm, 90 s) and baked (90 °C, 90 s). The PEDOT:PSS thus covers the whole glass slide and fills the “wells” defined in the second photolithographic patterning step. Peeling of the sacrificial layer and hard baking the device (125 °C, 1 h) thus define the channel width, the distance between source and drain contact defines the channel length. Immersing the devices in deionized water over night removes excess low molecular weight compounds.
Device Characterization: All experiments were done using a NaCl solution (100 m
Acknowledgements
This work was supported by the Marie Curie Initial Training Networks (ITN) project OrgBio.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
© 2017. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Abstract
Organic electrochemical transistors (OECTs) are receiving a great deal of attention as amplifying transducers for electrophysiology. A key limitation of this type of transistors, however, lies in the fact that their output is a current, while most electrophysiology equipment requires a voltage input. A simple circuit is built and modeled that uses a drain resistor to produce a voltage output. It is shown that operating the OECT in the saturation regime provides increased sensitivity while maintaining a linear signal transduction. It is demonstrated that this circuit provides high quality recordings of the human heart using readily available electrophysiology equipment, paving the way for the use of OECTs in the clinic.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Department of Bioelectronics, Ecole Nationale Supérieure des Mines, CMP‐EMSE, MOC, Gardanne, France
2 Department of Bioelectronics, Ecole Nationale Supérieure des Mines, CMP‐EMSE, MOC, Gardanne, France; MicroVitae Technologies, Hôtel Technologique, Meyreuil, France
3 Institut de Neurosciences des Systèmes, Aix‐Marseille Université, INS/Inserm, Marseille, France




